Methiye Mancak,Dudu Altintas,Yasemin Balaban et al.
Methiye Mancak et al.
The liver is the main organ for metabolic and detoxification reactions in the body. Therefore, its diseases can be associated with both metabolic disorders, such as insulin resistance, obesity, diabetes, or dyslipidemia, and exogenous insul...
Kadir Intas
Kadir Intas
Herbal medicines are widely used worldwide to treat minor ailments and prevent disease. Scotch pine (Pinus sylvestris) has many medicinal applications but is most well-known for its antiseptic properties and beneficial effects on the respir...
Case Reports
Hepatology forum. 2024 Jan 16;5(1):47-48. DOI:10.14744/hf.2022.2022.0046 2024
Effect of probiotics supplementation on liver stiffness and steatosis in patients with NAFLD [0.03%]
补充益生菌对非酒精性脂肪肝病患者肝脏硬度和脂肪变性的影响
Shahinul Alam,Pallab Kumar Datta,Mahabubul Alam et al.
Shahinul Alam et al.
Background and aim: To compare the effects of probiotics on liver stiffness and steatosis in obese and non-obese patients with nonalcoholic fatty liver disease (NAFLD),the pragmatic clinical trial included 50 obese body m...
EP-01: Association of genetic polymorphisms of OATP with susceptibility to hepatocellular carcinoma in hepatitis C patients who achieved SVR by direct acting antivirals [0.03%]
DAAs治愈的丙型肝炎患者中OATP基因多态性与肝细胞癌易感性的关联研究
Zuhal Mert Altintas,Serkan Yaras,Engin Altintas
Zuhal Mert Altintas
OBJECTIVES: Simeprevir, daclatasvir, ledipasvir, paritaprevir and ritonavir are all substrates and inhibitors of the organic anion transporting polypeptide (OATP1B1 transporter, whereas sofosbuvir, ombitasvir and dasabuvir are not substrate...
Case Reports
Hepatology forum. 2021 Jan 30;2(Suppl 1):1-25. DOI: 2021
TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease [0.03%]
非酒精性脂肪肝病的临床评估和管理实践指南
Yusuf Yilmaz,Mujdat Zeybel,Gupse Adali et al.
Yusuf Yilmaz et al.
Nonalcoholic fatty liver disease (NAFLD) is a multisystem disease and is significantly associated with obesity, insulin resistance, type 2 diabetes mellitus, metabolic syndrome, and cardiovascular disease. NAFLD has become the most prevalen...
Chronotype preference, sleep quality, and night-eating behaviors in patients with metabolic dysfunction-associated steatotic liver disease: Assessing the relationship with disease severity and fibrosis [0.03%]
代谢功能障碍相关肝脂肪变性患者的生物钟类型偏好、睡眠质量和夜间进食行为与疾病严重程度和纤维化的关系评估
Ayse Sakalli Kani,Ahmet Ozercan,Haluk Tarik Kani et al.
Ayse Sakalli Kani et al.
Background and aim: Our primary objective is to examine the variance in chronotype, night-eating patterns, and sleep quality in patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease. In addi...
The efficacy and tolerability of glecaprevir/pibrentasvir treatment in a real-world chronic hepatitis C patients cohort [0.03%]
Grazoprevir/elbasvir治疗现实世界慢性丙型肝炎患者的有效性和耐受性
Serkan Yaras,Mehmet Demir,Sezgin Barutcu et al.
Serkan Yaras et al.
Background and aim: The aims of the present study were to evaluate the real-life efficacy and tolerability of glecaprevir (GLE)/pibrentasvir (PIB) in the treatment of patients with chronic hepatitis C (CHC). ...
Protective/preventive effects of quercetin against cyclophosphamide-induced hepatic inflammation, apoptosis and fibrosis in rats [0.03%]
檞皮素对环磷酰胺致大鼠肝炎、肝细胞凋亡及肝纤维化的保护作用研究
Sibel Turedi
Sibel Turedi
Background and aim: The purpose of this study was to investigate the hepatoprotective effects of quercetin, a potent antioxidant, against hepatotoxicity caused by cyclophosphamide (CYC) in the rat liver using histopatholo...
Yusuf Yilmaz
Yusuf Yilmaz
Prevalence and predictors of metabolic-associated fatty liver disease in liver transplant recipients: A cross-sectional prospective study [0.03%]
肝移植受者中与代谢相关性脂肪性肝病的流行率及预测因素：一项横断面研究
Gupse Adali,Nermin Mutlu Bilgic,Ahmet Emre Kalaman et al.
Gupse Adali et al.
Background and aim: Metabolic-associated fatty liver disease (MAFLD) has emerged as a significant global health concern. However, the prevalence and predictors of MAFLD in post-liver transplantation (LT) patients remain u...